https://www.selleckchem.com/pr....oducts/k-ras-g12c-in
The objective of this study was to quantitatively evaluate the effects of daily teriparatide on rheumatoid arthritis patients using predicted bone strength (PBS) assessed by quantitative computed tomography-based finite-element analysis (QCT/FEA) and using bone mineral density (BMD) assessed by dual-energy X-ray absorptiometry (DXA), and to prospectively investigate clinical determinants associated with PBS and BMD increases. Participants comprised 39 patients (mean age, 69years; disease activity score assessing 28 joints
Like
Comment
Share
